NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE253387 Query DataSets for GSE253387
Status Public on Mar 26, 2024
Title DNAJC9 prevents CENP-A mislocalization and chromosomal instability by maintaining the fidelity of H3-H4 supply chains
Organism Homo sapiens
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary The centromeric histone H3 variant CENP-A is overexpressed in many cancers. Mislocalization of CENP-A to non-centromeric regions contributes to chromosomal instability (CIN), a hallmark of cancer. Despite these observations, pathways that promote and prevent CENP-A mislocalization remain poorly defined. Here, we performed a genome-wide RNAi screen to identify regulators of CENP-A localization. We identified DNAJC9, a J-domain protein as a lead candidate from the screen and showed that cells depleted for DNAJC9 exhibit mislocalization of CENP-A, enrichment of CENP-A in chromatin, and CIN phenotypes. Global interactome analysis showed an enhanced interaction of CENP-A with the replication-associated H3-H4 chaperone MCM2 in DNAJC9-depleted cells and co-depletion of MCM2 and DNAJC9 suppressed CENP-A mislocalization. Furthermore, we showed that cells ablated for the ability of DNAJC9 to promote the proper folding of H3–H4, exhibit CENP-A mislocalization. CUT&RUN Sequencing analysis of genome-wide CENP-A occupancy in DNAJC9-depleted cells identified 16,603 sites of non-centromeric localization, that broadly overlapped with open chromatin regions. Our comprehensive analysis has identified factors that prevent mislocalization of CENP-A and has defined DNAJC9 as an important safeguard that prevents CENP-A mislocalization and CIN.
 
Overall design CUT&RUN Sequencing of CENP-A in siNegative and siDNAJC9 transfected hTERT-RPE1-Tet-GFP-CENP-A cells treated with 1 ug/ml DOX for 48 hrs. Two biological repeats per condition were analysed with Mouse anti-CENP-A antibody and Mouse anti-IgG was used as control.
 
Contributor(s) Balachandra V, Shrestha RL, Hammond CM, Lin S, Sevilla S, Basrai MA
Citation(s) 38600242
Submission date Jan 16, 2024
Last update date Jun 26, 2024
Contact name Vinutha Balachandra
Organization name National Institute for Health
Department National Cancer Institute, Genetics Branch
Lab Yeast Genome Stability Section
Street address 10 Center Drive
City Bethesda
State/province MD
ZIP/Postal code 20892
Country USA
 
Platforms (1)
GPL30173 NextSeq 2000 (Homo sapiens)
Samples (6)
GSM8019615 sinegative control, IgG, rep2
GSM8019616 sinegative control, CENPA, rep1
GSM8019617 sinegative control, CENPA, rep3
Relations
BioProject PRJNA1065442

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE253387_RAW.tar 473.6 Mb (http)(custom) TAR (of BED, BIGWIG)
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap